Mechanisms Underlying Aberrant Glycosylation of MUC1 Mucin in Breast Cancer Cells

European Journal of Biochemistry

Volumn 233, Issue 2, 1995, Pages 607-617

  Brockhausen, Inka ^a,b   Yang, Ji‐Mao ^a   Burchell, Joy ^c   Whitehouse, Caroline ^c   Taylor‐Papadimitriou, Joyce ^c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

breast cancer cells; glycosyltransferases; MUC1 mucin; O glycosylation; sulfation

Indexed keywords

MUCIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMAL; BASE SEQUENCE; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CELL LINE; FEMALE; FUCOSYLTRANSFERASES; GLYCOSYLATION; GLYCOSYLTRANSFERASES; HUMAN; MICE; MOLECULAR SEQUENCE DATA; N-ACETYLGALACTOSAMINYLTRANSFERASES; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASM PROTEINS; SIALYLTRANSFERASES; SULFOTRANSFERASES; SUPPORT, NON-U.S. GOV'T;

EID: 0028841588     PISSN: 00142956     EISSN: 14321033     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1995.607_2.x     Document Type: Article

References (49)

1. Molecular cloning and expression of human tumor‐associated polymorphic epithelial mucin
2. Influence of acceptor substrate primary amino acid sequence on the activity of human UDP‐N‐acetylgalactosamine: polypeptide N‐acetylgalactosaminyltransferase. Studies with the MUC1 tandem repeat
3. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM‐3 is selectively exposed in a range of primary carcinomas
4. Effect of modification of carbohydrate side chains on the reactivity of antibodies with core‐protein epitopes of the MUC1 gene product
5. Mucins in breast cancer: recent immunological advances
6. The polymorphic epithelial mucin as a target for immunotherapy
7. Immunization of breast cancer patients using a synthetic sialyl‐Tn glycoconjugate plus Detox adjuvant
8. Human B‐cell immune‐response to the polymorphic epithelial mucin
9. Cytotoxic T‐lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells
10. Humoral immunity against a tandem repeat epitope of human mucin MUC‐1 in sera from breast, pancreatic, and colon cancer patients
11. Development and characterization of breast cancer reactive monoclonal antibodies to the core protein of the human milk mucin
12. A short sequence, within the amino acid tandem repeat of a cancer‐associated mucin, contains immunodominant epitopes
13. Structures of mucin‐type sugar chains of the galactosyltransferasc purified from human milk. Occurrence of the ABO and Lewis blood group determinants
14. Structures of neutral O‐linked polylactosaminoglycans on human skim milk mucins. A novel type of linearly extended poly‐N‐acetyllactosamine backbones with Galβ(1–4) GlcNAβ(1–6) repeating units
15. Structures of acidic O‐linked polylactosaminoglycans on human skim milk mucins
16. Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT‐20 human breast carcinoma cell line
17. Analysis of carbohydrate composition and structure in radiolabeled immunoprecipitates: application to breast and ovarian cancer mucins
18. Biosynthesis of O‐glycans of the N‐acetylgalactosamine‐α‐Ser/Thr linkage type
19. Alterations of O‐glycan biosynthesis in human colon‐cancer tissues
20. Glycosyltransferase Changes upon Differentiation of CaCo‐2 Human Colonic Adenocarcinoma Cells
21. Synthese von O‐Glycopeptid‐Sequenzen des N‐terminus von Interleukin‐2
22. Mucin Synthesis VI. UDP‐GlcNAc:GalNAc‐R β3–N‐acelylglucosaminyl‐transferase and UDP‐GlcNAc:GlcNAcβ1‐3GalNAc‐R (GlcNAc to GalNAc) β6–N‐acetylglucosaminyltransferase from pig and rat colon mucosa
23. Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus
24. Collagen‐induced rapid morphogenesis of human mammary epithelial cells: The role of the α2β integrin
25. A human cell line from a pleural effusion derived from a breast carcinoma
26. Establishment and characterization of a cell line of human breast cancer origin
27. Cultivation of human breast carcinomas
28. Biosynthesis of O‐glycans in leukocytes from normal donors and from patients with chronic and acute myelogenous leukemia: increase in O‐glycan core‐2 UDP‐GlcNAc: Galβ3GalNAc‐R (GlcNAc to GalNAc) β6–N‐acetylglucosaminyllransferase in leukemic cells
29. O‐glycan biosynthesis in human colorectal adenoma cells during progression to cancer
30. Expression cloning of a cDNA encoding UDP‐GlcNAc transferase by gene transfer into CHO cells expressing polyoma large T‐antigen
31. N‐acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor extracts
32. Processing of O‐glycan core‐1, Galβ1‐3GalNAcαR (GlcNAc to GalNAc) β‐6–N‐acetylglucosaminyltransferase and CMP‐sialic acid‐Galβ1 ‐3Gal‐NAc‐R α3–sialyltransferase
33. Characterization of sulfotransferasc activity from rat colonic mucosa synthesizing sulfaled O‐glycan core 1,3–sulfate‐Galβ1‐3GalNAcα‐R (1995)
34. Isolation and expression of a cDNA clone encoding a bovine UDP‐GalNAc:polypeptide N‐acetylgalactosaminyltransferase
35. Purification and cDNA cloning of a Human UDP‐GalNAc:polypeptide N‐acetylgalactosaminyltransferase
36. UDP‐GalNAc: polypeptide N‐acetylgalactosaminyltransferase: Identification and separation of two distinct transferase activities
37. Three genes that encode human beta‐galactoside alpha2,3–sia‐lyltransferase. Structural analysis and chromosomal mapping studies
38. Synthesis of O‐glycan core 3: Characterization of UDP‐GlcNAc: GalNAc β3‐N‐acetylglucosaminyltransferase activity from colonic mucosal tissues and lack of the activity in human cancer cell lines, (1995)
39. Structure and expression of the human polymorphic epithelial mucin gene: An expressed VNTR unit
40. Preferred Conformations and Dynamics of five core structures of Mucin‐type O‐glycans determined by NMR spectroscopy and force field calculations
41. Presence of Cytidine 5′‐Monophospho‐N‐Acetylneuraminic Acid:Gal β1‐3GalNAc‐R α(2‐3)‐Sia‐lyltransferase in Normal Human Leukocytes and Increased Activity of this Enzyme in Granulocytes from Chronic Myelogenous Leukemia Patients
42. Sialyltransferase activity in FR3T3 cells transformed with ras oncogen: decreased CMP‐Neu5Ac: Galβ1‐3GalNAc α‐2,3–sia‐lyltransferase
43. A glycon specificity of fetal calf liver and ovine and porcine submaxillary gland α‐N‐acetylgalactosaminide α2‐6 sialyltransferase
44. Pancarcinoma T and Tn epilopes: Autoimmunogens and diagnostic markers that reveal incipient carcinomas and help establish prognosis
45. Sialosyl‐Tn: a novel mucin antigen associated with poor prognosis in colorectal cancer patients
46. Active specific immunotherapy against adenocarcinomas
47. Cloning and expression of Galβ1,3GalNAc‐specific GalNAc α2,6–sialyltransferase